Details
Study Summary
FDA decided that no new action on behalf of pediatrics is necessary at this time, based on available information.
Result(s) (1)
Metabolic Effects of Second Generation Antipsychotics in Youth, Subprojects 1, 2, and 3
Related Publication(s) and/or Presentation(s) (1)
Publication: Adherence to Guidelines for Glucose Assessment in Starting Second-Generation Antipsychotics